LUPHARMACEUTICAL CO., LTD

Company Description

Having established itself as a major Manufacturer and Exporter of API intermediate around the world, LUPHARMACEUTICAL CO., LTD had been earning More than 6 Million US Dollar annually since its inception 15 Years ago. With an export rate of about US$5 Million - US$10 Million earned yearly, the estimated market share of LUPHARMACEUTICAL CO., LTD is Australia,Canada,South Korea,Nigeria,United Kingdom. Having said all of this, European and Oceanic market is still yet to be discovered by the industry; however, this graph may change ahead in the future. Originating from Hangzhou, Zhejiang, China, LUPHARMACEUTICAL CO., LTD started off with an initial investment of US$2.5 Million in 2005. A Private Limited with Have Own Export License; the company plans to expand its roots in different countries in the coming years. For any further details on Amprolium products, feel free to contact andy on provided details.